Therefore, it was hypothesized that SZJN prescription may regulate AChE, CHRM1, and CHRM2 via the cholinergic signaling pathway, which is critical in the pharmacological treatment of VD. This evidence concerns the gene CHRM1 and sexually transmitted disease.